Gillson Sciences is proud to announce its official formation, marking a significant milestone in the evolution of scientific services that support quality, safety, and regulatory excellence across the healthcare ecosystem. Gillson combines deep expertise in laboratory testing, monitoring, and advisory services to empower clients across the pharmaceuticals, biopharma, medical devices, healthcare, and environmental sciences sectors.
Formed in January 2025, Gillson Sciences unites two industry leaders—Azzur Labs (now Gillson Testing) and Micro Measurement Laboratories (MML)—to deliver comprehensive, science-driven solutions across the product lifecycle. With GMP-compliant laboratories in Pennsylvania, Illinois, and California, and field personnel nationwide, Gillson is positioned to serve clients with precision, integrity, and responsiveness.
Jason Fischer has been named CEO, bringing over a decade of leadership experience from UL Solutions, where he spearheaded strategic growth through partnerships and more than 40 acquisitions. His vision for Gillson is clear: “Gillson Sciences represents the opportunity to build a market leader in testing, monitoring, and advisory solutions focused on advancing human health,” said Fischer. “We have a great foundation with our outstanding employees and clients, a motivating mission, and the right partners to deliver on our plan”.
Gillson’s mission is to support clients in developing, sourcing, manufacturing, and commercializing safe and effective products. Its services are considered mission-critical by regulatory bodies, enabling clients to maintain operations and meet stringent compliance demands.
Looking ahead, Gillson will continue to expand its capabilities within the testing, inspection, certification, and compliance (TICC) sector. The company is actively seeking partnerships with organizations that share its commitment to scientific excellence and regulatory integrity.
